Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.92 USD | -1.62% | +3.02% | +20.00% |
13/05 | Avalo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
17/04 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.00% | 1.15Cr | |
+44.48% | 5.4TCr | |
+43.57% | 4.2TCr | |
-0.86% | 4.19TCr | |
-7.59% | 2.84TCr | |
+12.30% | 2.64TCr | |
-21.83% | 1.9TCr | |
+7.15% | 1.3TCr | |
+29.40% | 1.23TCr | |
+25.15% | 1.22TCr |
- Stock Market
- Equities
- AVTX Stock
- News Avalo Therapeutics, Inc.
- Earnings Flash (AVTX) AVALO THERAPEUTICS Reports Q3 Revenue $236,000